Figure 2 | Modern Pathology

Figure 2

From: Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome

Figure 2

Kaplan–Meier estimates show a statistically significant survival difference between patients with abnormal copy neutral loss of heterozygosity and patients with normal chromosome genomic array testing (overall P=0.04). The individual comparisons were P=0.04 with copy neutral loss of heterozygosity, and P=0.05 without copy neutral loss of heterozygosity (using normal as the reference).

Back to article page